Eur Rev Med Pharmacol Sci 2022; 26 (12): 4535-4544
DOI: 10.26355/eurrev_202206_29093

COVID-19 and neurodegenerative diseases

Y.-W. Fu, H.-S. Xu, S.-J. Liu

Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed by the Province and Ministry, Guangxi Key Laboratory of Regenerative Medicine & Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education, Guangxi Medical University, Shuangyong Road, Nanning, P.R. China. heming_liu@163.com


OBJECTIVE: The pandemic of Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues, and SARS-CoV-2 variants continue to emerge. In addition to typical fever and respiratory symptoms, many patients with COVID-19 experience a variety of neurological complications. In this review, we analyzed and reviewed the current status and possible mechanisms between COVID-19 and several typical neurodegenerative diseases, particularly Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, hoping to propose the potential direction of further research and concern.

MATERIALS AND METHODS: Electronic literature search of the databases (Medline/PubMed, Web of Science, and Google Scholar). The keywords used were COVID-19, SARS-CoV-2, neurodegenerative disease, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. The retrieved relevant articles were reviewed and critically analyzed.

RESULTS: SARS-CoV-2 is a highly neuroinvasive neurotropic virus that invades cells through angiotensin-converting enzyme 2 (ACE2) receptor-driven pathway. SARS-CoV-2 neuroinvasion, neuroinflammation, and blood-brain barrier (BBB) dysfunction may contribute to the pathogenesis of neurodegenerative diseases.

CONCLUSIONS: Some patients with neurodegenerative diseases have already shown more susceptibility to SARS-CoV-2 infection and significantly higher mortality due to the elderly population with underlying diseases. Moreover, SARS-CoV-2 could cause damage to the central nervous system (CNS) that may substantially increase the incidence of neurodegenerative diseases and accelerate the progression of them.

Free PDF Download

To cite this article

Y.-W. Fu, H.-S. Xu, S.-J. Liu
COVID-19 and neurodegenerative diseases

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 12
Pages: 4535-4544
DOI: 10.26355/eurrev_202206_29093